Cargando…
Analytical Investigations of Toxic p-Phenylenediamine (PPD) Levels in Clinical Urine Samples with Special Focus on MALDI-MS/MS
Para-phenylenediamine (PPD) is a common chromophoric ingredient in oxidative hair-dyes. In some African countries like Sudan, Egypt and Morocco but also in India this chemical is used alone or in combination with colouring extracts like Henna for dyeing of the hair or the skin. Excessive dermal expo...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3150356/ https://www.ncbi.nlm.nih.gov/pubmed/21829608 http://dx.doi.org/10.1371/journal.pone.0022191 |
_version_ | 1782209538021130240 |
---|---|
author | Hooff, Gero P. van Huizen, Nick A. Meesters, Roland J. W. Zijlstra, Eduard E. Abdelraheem, Mohamed Abdelraheem, Waleed Hamdouk, Mohamed Lindemans, Jan Luider, Theo M. |
author_facet | Hooff, Gero P. van Huizen, Nick A. Meesters, Roland J. W. Zijlstra, Eduard E. Abdelraheem, Mohamed Abdelraheem, Waleed Hamdouk, Mohamed Lindemans, Jan Luider, Theo M. |
author_sort | Hooff, Gero P. |
collection | PubMed |
description | Para-phenylenediamine (PPD) is a common chromophoric ingredient in oxidative hair-dyes. In some African countries like Sudan, Egypt and Morocco but also in India this chemical is used alone or in combination with colouring extracts like Henna for dyeing of the hair or the skin. Excessive dermal exposure to PPD mainly leads to the N-mono- and N,N′-diacetylated products (MAPPD, DAPPD) by N-acetyltransferase 1 and 2 (NAT1 and 2) catalyzed reactions. Metabolites and PPD are mainly excreted via renal clearance. Despite a low risk of intoxication when used in due form, there are numerous cases of acute intoxication in those countries every year. At the ENT Hospital - Khartoum (Sudan) alone more than 300 cases are reported every year (∼10% fatal), mostly caused by either an accidental or intended (suicidal) high systemic exposure to pure PPD. Intoxication leads to a severe clinical syndrome including laryngeal edema, rhabdomyolysis and subsequent renal failure, neurotoxicity and acute toxic hepatitis. To date, there is no defined clinical treatment or antidote available and treatment is largely supportive. Herein, we show the development of a quick on-site identification assay to facilitate differential diagnosis in the clinic and, more importantly, the implementation of an advanced analytical platform for future in-depth investigations of PPD intoxication and metabolism is described. The current work shows a sensitive (∼25 µM) wet chemistry assay, a validated MALDI-MS/MS and HPLC-UV assay for the determination of PPD and its metabolites in human urine. We show the feasibility of the methods for measuring PPD over a range of 50–1000 µM. The validation criteria included linearity, lower limit of quantification (LLOQ), accuracy and precision, recovery and stability. Finally, PPD concentrations were determined in clinical urine samples of cases of acute intoxication and the applied technique was expanded to identify MAPPD and DAPPD in the identical samples. |
format | Online Article Text |
id | pubmed-3150356 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-31503562011-08-09 Analytical Investigations of Toxic p-Phenylenediamine (PPD) Levels in Clinical Urine Samples with Special Focus on MALDI-MS/MS Hooff, Gero P. van Huizen, Nick A. Meesters, Roland J. W. Zijlstra, Eduard E. Abdelraheem, Mohamed Abdelraheem, Waleed Hamdouk, Mohamed Lindemans, Jan Luider, Theo M. PLoS One Research Article Para-phenylenediamine (PPD) is a common chromophoric ingredient in oxidative hair-dyes. In some African countries like Sudan, Egypt and Morocco but also in India this chemical is used alone or in combination with colouring extracts like Henna for dyeing of the hair or the skin. Excessive dermal exposure to PPD mainly leads to the N-mono- and N,N′-diacetylated products (MAPPD, DAPPD) by N-acetyltransferase 1 and 2 (NAT1 and 2) catalyzed reactions. Metabolites and PPD are mainly excreted via renal clearance. Despite a low risk of intoxication when used in due form, there are numerous cases of acute intoxication in those countries every year. At the ENT Hospital - Khartoum (Sudan) alone more than 300 cases are reported every year (∼10% fatal), mostly caused by either an accidental or intended (suicidal) high systemic exposure to pure PPD. Intoxication leads to a severe clinical syndrome including laryngeal edema, rhabdomyolysis and subsequent renal failure, neurotoxicity and acute toxic hepatitis. To date, there is no defined clinical treatment or antidote available and treatment is largely supportive. Herein, we show the development of a quick on-site identification assay to facilitate differential diagnosis in the clinic and, more importantly, the implementation of an advanced analytical platform for future in-depth investigations of PPD intoxication and metabolism is described. The current work shows a sensitive (∼25 µM) wet chemistry assay, a validated MALDI-MS/MS and HPLC-UV assay for the determination of PPD and its metabolites in human urine. We show the feasibility of the methods for measuring PPD over a range of 50–1000 µM. The validation criteria included linearity, lower limit of quantification (LLOQ), accuracy and precision, recovery and stability. Finally, PPD concentrations were determined in clinical urine samples of cases of acute intoxication and the applied technique was expanded to identify MAPPD and DAPPD in the identical samples. Public Library of Science 2011-08-04 /pmc/articles/PMC3150356/ /pubmed/21829608 http://dx.doi.org/10.1371/journal.pone.0022191 Text en Hooff et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Hooff, Gero P. van Huizen, Nick A. Meesters, Roland J. W. Zijlstra, Eduard E. Abdelraheem, Mohamed Abdelraheem, Waleed Hamdouk, Mohamed Lindemans, Jan Luider, Theo M. Analytical Investigations of Toxic p-Phenylenediamine (PPD) Levels in Clinical Urine Samples with Special Focus on MALDI-MS/MS |
title | Analytical Investigations of Toxic p-Phenylenediamine (PPD) Levels in Clinical Urine Samples with Special Focus on MALDI-MS/MS |
title_full | Analytical Investigations of Toxic p-Phenylenediamine (PPD) Levels in Clinical Urine Samples with Special Focus on MALDI-MS/MS |
title_fullStr | Analytical Investigations of Toxic p-Phenylenediamine (PPD) Levels in Clinical Urine Samples with Special Focus on MALDI-MS/MS |
title_full_unstemmed | Analytical Investigations of Toxic p-Phenylenediamine (PPD) Levels in Clinical Urine Samples with Special Focus on MALDI-MS/MS |
title_short | Analytical Investigations of Toxic p-Phenylenediamine (PPD) Levels in Clinical Urine Samples with Special Focus on MALDI-MS/MS |
title_sort | analytical investigations of toxic p-phenylenediamine (ppd) levels in clinical urine samples with special focus on maldi-ms/ms |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3150356/ https://www.ncbi.nlm.nih.gov/pubmed/21829608 http://dx.doi.org/10.1371/journal.pone.0022191 |
work_keys_str_mv | AT hooffgerop analyticalinvestigationsoftoxicpphenylenediamineppdlevelsinclinicalurinesampleswithspecialfocusonmaldimsms AT vanhuizennicka analyticalinvestigationsoftoxicpphenylenediamineppdlevelsinclinicalurinesampleswithspecialfocusonmaldimsms AT meestersrolandjw analyticalinvestigationsoftoxicpphenylenediamineppdlevelsinclinicalurinesampleswithspecialfocusonmaldimsms AT zijlstraeduarde analyticalinvestigationsoftoxicpphenylenediamineppdlevelsinclinicalurinesampleswithspecialfocusonmaldimsms AT abdelraheemmohamed analyticalinvestigationsoftoxicpphenylenediamineppdlevelsinclinicalurinesampleswithspecialfocusonmaldimsms AT abdelraheemwaleed analyticalinvestigationsoftoxicpphenylenediamineppdlevelsinclinicalurinesampleswithspecialfocusonmaldimsms AT hamdoukmohamed analyticalinvestigationsoftoxicpphenylenediamineppdlevelsinclinicalurinesampleswithspecialfocusonmaldimsms AT lindemansjan analyticalinvestigationsoftoxicpphenylenediamineppdlevelsinclinicalurinesampleswithspecialfocusonmaldimsms AT luidertheom analyticalinvestigationsoftoxicpphenylenediamineppdlevelsinclinicalurinesampleswithspecialfocusonmaldimsms |